Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of NFATC1 mRNA | decreases expression | 18648102
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of NFATC1 mRNA | decreases expression | 12419474
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NFATC1 mRNA | affects expression | 17562736
|
C011512 |
alpha-naphthoflavone |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein] | affects localization|decreases reaction | 19028555
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of NFATC1 mRNA | decreases expression | 20064835
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of NFATC1 mRNA | decreases expression | 12419474
|
D016572 |
Cyclosporine |
Cyclosporine inhibits the reaction [Oxygen deficiency affects the localization of NFATC1 protein] | affects localization|decreases reaction | 19028555
|
D016572 |
Cyclosporine |
Cyclosporine inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein] | affects localization|decreases reaction | 19028555
|
D016572 |
Cyclosporine |
Cyclosporine inhibits the reaction [Phenylephrine results in increased localization of and results in increased activity of NFATC1 protein] | decreases reaction|increases activity|increases localization | 19349967
|
C014347 |
decitabine |
decitabine results in decreased expression of NFATC1 mRNA | decreases expression | 17785578
|
D017313 |
Fenretinide |
Fenretinide results in decreased expression of NFATC1 mRNA | decreases expression | 16467112
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide inhibits the reaction [Ionomycin results in decreased phosphorylation of NFATC1 protein] | decreases phosphorylation|decreases reaction | 12203019
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased activity of NFATC1 protein | decreases activity | 12203019
|
D019271 |
Hypoxanthine |
Hypoxanthine results in decreased activity of NFATC1 protein | decreases activity | 12203019
|
D015759 |
Ionomycin |
Hydrogen Peroxide inhibits the reaction [Ionomycin results in decreased phosphorylation of NFATC1 protein] | decreases phosphorylation|decreases reaction | 12203019
|
D015759 |
Ionomycin |
Ionomycin results in decreased phosphorylation of NFATC1 protein | decreases phosphorylation | 12203019
|
C058346 |
N-(4-methoxyphenyl)retinamide |
N-(4-methoxyphenyl)retinamide results in decreased expression of NFATC1 mRNA | decreases expression | 16467112
|
D010100 |
Oxygen |
Cyclosporine inhibits the reaction [Oxygen deficiency affects the localization of NFATC1 protein] | affects localization|decreases reaction | 19028555
|
D010100 |
Oxygen |
Oxygen deficiency affects the localization of NFATC1 protein | affects localization | 19028555
|
D010656 |
Phenylephrine |
Cyclosporine inhibits the reaction [Phenylephrine results in increased localization of and results in increased activity of NFATC1 protein] | decreases reaction|increases activity|increases localization | 19349967
|
D010656 |
Phenylephrine |
KCND2 protein inhibits the reaction [Phenylephrine results in increased activity of NFATC1 protein] | decreases reaction|increases activity | 12403671
|
D010656 |
Phenylephrine |
Phenylephrine results in increased localization of and results in increased activity of NFATC1 protein | increases activity|increases localization | 19349967
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | decreases reaction|increases expression | 19495926
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of NFATC1 mRNA | affects cotreatment|decreases expression | 19059307
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA] | affects cotreatment|decreases reaction|increases expression | 16267019
|
C084904 |
Ro 41-5253 |
Ro 41-5253 inhibits the reaction [Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | decreases reaction|increases expression | 17291456
|
C084904 |
Ro 41-5253 |
Ro 41-5253 inhibits the reaction [tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | decreases reaction|increases expression | 17291456
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of NFATC1 mRNA | affects cotreatment|decreases expression | 19059307
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of NFATC1 mRNA | increases expression | 19031437
|
D013749 |
Tetrachlorodibenzodioxin |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein] | affects localization|decreases reaction | 19028555
|
D013749 |
Tetrachlorodibenzodioxin |
Cyclosporine inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein] | affects localization|decreases reaction | 19028555
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the localization of NFATC1 protein | affects localization | 19028555
|
D019284 |
Thapsigargin |
Thapsigargin promotes the reaction [PPP3CA protein results in decreased phosphorylation of NFATC1 protein] | decreases phosphorylation|increases reaction | 10898953
|
D014212 |
Tretinoin |
Ro 41-5253 inhibits the reaction [Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | decreases reaction|increases expression | 17291456
|
D014212 |
Tretinoin |
Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | decreases reaction|increases expression | 17291456
|
C011559 |
tributyltin |
Ro 41-5253 inhibits the reaction [tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | decreases reaction|increases expression | 17291456
|
C011559 |
tributyltin |
tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | decreases reaction|increases expression | 17291456
|
C030665 |
triphenyltin |
triphenyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | decreases reaction|increases expression | 17291456
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.35 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.66 | 15322242 14514962 11752688 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.68 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
4.35 | 16759491 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.49 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
4.49 | 10697514 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
10.56 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.56 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
10.56 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.41 | 17308373 17451421 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.46 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.27 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.27 | 16183991 16162502 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.98 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.78 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
4.07 | 17084956 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.65 | 10982225 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.86 | 20872349 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.88 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.95 | 17460149 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.13 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.13 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.22 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.29 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.78 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
6.72 | 16391483 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.72 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.22 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.22 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.83 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.36 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.36 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.60 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.64 | 15746008 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.35 | 15306635 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.29 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.09 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.18 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.82 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
6.82 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
6.82 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
6.82 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
6.82 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
6.82 | 17242785 16912660 17952589 17440819 15775269 17893378 17261762 15758505 17049068 15572757 16837676 17595753 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
6.82 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
6.82 | 19059307 19155303 21138602 15565566 15668708 11161223 17242785 16818667 17261762 18821012 19200415 20135344 19289846 18351453 19103187 19221464 21152245 18855134 16273361 20544844 20390343 19244106 20859285 19115204 19084267 19066611 19410462 19011961 19487384 16202921 18984771 19189212 19288272 18629630 17440819 19189210 20005174 19142967 16873071 20065188 17049068 18997820 18425577 17893378 18815881 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.82 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.82 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.40 | 16813970 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.35 | 16962696 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.65 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.32 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.97 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
13.61 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
13.61 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
13.61 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
13.61 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
13.61 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.61 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.61 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.40 | 16675471 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.77 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.59 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
13.75 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
13.75 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
13.75 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
13.75 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.75 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.94 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.94 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
10.87 | 15728586 11754973 11179087 17287366 17124262 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
10.87 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
10.87 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
11.52 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
11.52 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
11.52 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.86 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.86 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.14 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.14 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
12.33 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
12.33 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.00 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.41 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.41 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.97 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.50 | 12621046 15668235 8697196 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.50 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.43 | 15800139 |
MESH:D003092 |
Colitis |
|
resveratrol |
9.00 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
9.00 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.71 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
5.71 | 17191121 17148506 11134977 15741050 19056647 16640504 19440933 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.71 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.71 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
4.71 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
4.71 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
4.71 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.63 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.39 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.39 | 10589399 9142499 17551590 16925845 9125849 9211117 8800419 9224671 14991402 9664655 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.17 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.00 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.62 | 18759878 11298694 2524372 11906362 14531868 8970840 8156756 12868966 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.31 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
8.04 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
8.04 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.62 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
14.16 | 17451421 17308373 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
14.16 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
14.16 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
5.78 | 18289764 6482804 7440962 11289319 16192314 18648102 9022650 6679447 1440618 9328219 18692083 9653073 8291058 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
5.78 | 12540782 14986274 2444490 19164858 11743745 10915739 19739265 19420014 11739529 11421492 14725611 12705907 16393943 19085960 16781746 12958197 10663392 16227642 11529661 17522070 10774834 15968718 19923254 12594235 16485898 11287661 18713872 11834606 15619225 16081117 19370779 17906064 17562736 18071297 12153990 16177239 19416960 16109766 14550746 11461765 12392966 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.78 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.91 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.62 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.64 | 20016425 |
MESH:D004487 |
Edema |
|
Raloxifene |
10.55 | 15860553 |
MESH:D004487 |
Edema |
|
resveratrol |
10.55 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.55 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.30 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.30 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
14.40 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
14.40 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.40 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.92 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.03 | 16202921 19155303 17893378 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.03 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.86 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.66 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.19 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.19 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.37 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.37 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.16 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
12.16 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.16 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.12 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.27 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.83 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.34 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.99 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
19.59 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
19.59 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.59 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
19.59 | 17994277 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
5.03 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.48 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.03 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
11.31 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
11.31 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
11.31 | 17312396 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.98 | 17643826 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.86 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.40 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.41 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.41 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.97 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.51 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.51 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.51 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.40 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.23 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.16 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.33 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.71 | 15340226 12621046 16120746 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.99 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.85 | 18606429 15340226 16959395 16354765 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.13 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.13 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.83 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.38 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
9.60 | 11834736 18262572 |
MESH:D006943 |
Hyperglycemia |
|
triphenyltin |
9.60 | 10522495 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.85 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.75 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
15.62 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
15.62 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Quercetin |
15.62 | 18356687 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
15.62 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
15.62 | 18670907 18850075 |
MESH:D015228 |
Hypertriglyceridemia |
|
triphenyltin |
5.79 | 10522495 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.38 | 18502941 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.13 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.46 | 17600658 |
MESH:D007246 |
Infertility |
|
triphenyltin |
5.84 | 15205045 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.08 | 17581917 |
MESH:D007249 |
Inflammation |
|
resveratrol |
7.76 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.76 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.76 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
10.55 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
10.55 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.58 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.83 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.36 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.36 | 15992940 17551590 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.77 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.25 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.41 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.41 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
9.41 | 16962696 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.10 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.47 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.47 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.47 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.32 | 16973256 |
MESH:D007938 |
Leukemia |
|
decitabine |
10.00 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Quercetin |
10.00 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
10.00 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
8.99 | 19117987 17236224 18454857 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.99 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.85 | 17679729 18704418 19010910 18206229 18460780 19387464 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.85 | 19850784 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.27 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.36 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.36 | 16331271 19029980 19035177 16891316 17649720 16935935 16766008 19075265 17712046 16140955 19642359 17368321 16823087 17361223 17294898 17301526 17339181 17506722 15748426 12679006 9834237 17217047 16788101 19225113 17107899 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.85 | 16707609 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.17 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.02 | 17567588 15342952 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.08 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
4.77 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.77 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.77 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.77 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.59 | 12969438 11587558 19784758 16611625 19014921 12587719 16610002 19460945 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.07 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
13.47 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
13.47 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
13.47 | 20405173 19073162 19321006 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
13.47 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.47 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.16 | 1399818 3712494 598648 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
9.16 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.16 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
4.32 | 18339021 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.65 | 18520028 18816296 20464547 20135361 18569708 6695378 17053015 20869020 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
4.65 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.65 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.65 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.28 | 19470736 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.12 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.71 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
9.36 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
9.36 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
9.44 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
9.44 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.44 | 19196723 14580682 16827153 11731420 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.35 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.71 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
9.44 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
9.44 | 16270382 |
MESH:D008545 |
Melanoma |
|
resveratrol |
9.44 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
9.44 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.44 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.99 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.38 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.24 | 16940565 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.20 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.59 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.36 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.30 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
8.30 | 16274795 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
11.44 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
11.44 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
11.44 | 14749477 17049120 16490592 17164350 17935668 16267019 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.68 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.12 | 18608210 19010910 19157545 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.12 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
5.79 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.79 | 17188708 16456233 16525036 16317513 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.51 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.51 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
3.65 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.57 | 17322642 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.36 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.44 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.44 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.45 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
14.75 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
14.75 | 19116145 19470736 17925555 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
14.75 | 15958647 17353921 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
14.75 | 15185748 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
14.75 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.81 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.81 | 19189210 19196722 19200415 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.25 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.12 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.90 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
8.90 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.82 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.82 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.84 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.84 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
10.10 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
10.10 | 17929310 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.49 | 16303764 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.25 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.83 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.28 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
15.89 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
15.89 | 17893378 17823083 15758505 15579764 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
15.89 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
10.86 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
10.86 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
10.86 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.86 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.08 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.08 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
11.84 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
11.84 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
11.84 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.84 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
8.69 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
8.69 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.06 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
12.35 | 6228378 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
12.35 | 11550810 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.37 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.56 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
8.56 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.95 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.95 | 11896295 11222880 11399792 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.54 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
1.89 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
1.89 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.89 | 15731164 16220300 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.89 | 17718901 17804756 15767336 17675339 16731767 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.89 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.43 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.60 | 16723453 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.36 | 15770314 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.39 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.18 | 15827377 16314181 17058453 16317513 17520802 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
4.33 | 18339021 17627322 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.65 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
8.64 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
8.64 | 16303925 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.35 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.35 | 16116481 16283617 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.35 | 16862918 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.51 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
30.54 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
30.54 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
30.54 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
N-(4-methoxyphenyl)retinamide |
30.54 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
30.54 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
30.54 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
30.54 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
30.54 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.10 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.85 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.27 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.27 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.27 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.67 | 16837676 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.31 | 16321402 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.35 | 12563064 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.71 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.16 | 6582329 1399818 7505956 3712494 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
11.16 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.16 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.02 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
9.35 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.35 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.11 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
23.00 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
23.00 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
23.00 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
23.00 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
23.00 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
23.00 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
23.00 | 16712894 8653321 17572228 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.80 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
15.03 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
15.03 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
15.03 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.95 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
12.18 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
12.18 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.79 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.40 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.02 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.11 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.87 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.36 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.06 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.81 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.25 | 17120751 |